216 related articles for article (PubMed ID: 27172790)
1. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
3. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
Xu J; Müller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF; Beitler JJ; Shin DM; Chen ZG
Eur J Cancer; 2012 Jul; 48(11):1682-91. PubMed ID: 22341992
[TBL] [Abstract][Full Text] [Related]
5. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
Laban S; Giebel G; Klümper N; Schröck A; Doescher J; Spagnoli G; Thierauf J; Theodoraki MN; Remark R; Gnjatic S; Krupar R; Sikora AG; Litjens G; Grabe N; Kristiansen G; Bootz F; Schuler PJ; Brunner C; Brägelmann J; Hoffmann TK; Perner S
Oncotarget; 2017 Feb; 8(9):14719-14735. PubMed ID: 28146422
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.
Bosch FX; Andl C; Abel U; Kartenbeck J
Int J Cancer; 2005 May; 114(5):779-90. PubMed ID: 15609307
[TBL] [Abstract][Full Text] [Related]
7. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
[TBL] [Abstract][Full Text] [Related]
8. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes.
da Cunha IW; Souza MJ; da Costa WH; Amâncio AM; Fonseca FP; Zequi Sde C; Lopes A; Guimarães GC; Soares F
Urol Oncol; 2016 Oct; 34(10):433.e19-26. PubMed ID: 27381894
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.
Nijkamp MM; Span PN; Hoogsteen IJ; van der Kogel AJ; Kaanders JH; Bussink J
Radiother Oncol; 2011 Jun; 99(3):344-8. PubMed ID: 21684617
[TBL] [Abstract][Full Text] [Related]
11. Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
Huang DH; Su L; Peng XH; Zhang H; Khuri FR; Shin DM; Chen ZG
Nanotechnology; 2009 Jun; 20(22):225102. PubMed ID: 19433879
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome.
Mattijssen V; Peters HM; Schalkwijk L; Manni JJ; van 't Hof-Grootenboer B; de Mulder PH; Ruiter DJ
Int J Cancer; 1993 Oct; 55(4):580-5. PubMed ID: 8406985
[TBL] [Abstract][Full Text] [Related]
14. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
15. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
16. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
17. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
